Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma-论文-万方医学网

Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

导出原文传递

翻译打印收藏纠错

作者： Spira, Alexander ^[1] ; Zhou, Xiaolei ^[2] ; Chen, Lei ^[3] ; Gnanasakthy, Ari ^[4] ; Wang, Luqiang ^[5] ; Ungar, David ; Curiel, Rafael ; Liao, Laura ; Radford, John ; Kahl, Brad

作者单位： US Oncol Res,Johns Hopkins Med ^[1] RTI Hlth Solut ^[2] ADC Therapeut Amer Inc ^[3] NIHR Manchester Clin Res Facil,Christie NHS Fdn Trust ^[4] Sch Med,Washington Univ ^[5]

关键词 Patient-reported Clinical trial Non-Hodgkin lymphoma FACT-Lym EQ-5D NON-HODGKIN-LYMPHOMA OUTCOMES THERAPY

发布时间 2022-07-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

相似文献

相关期刊

检索历史清除